argenx to Present at Upcoming Investor Conferences
argenx (Nasdaq: ARGX), a global immunology company, has announced its management team's participation in two upcoming investor conferences in September 2025. The company will present at the 2025 Wells Fargo Healthcare Conference on September 4 at 8:00 a.m. ET in Boston, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8 at 7:00 a.m. ET in New York.
Investors can access live webcasts of both presentations through the Investors section of argenx's website, with replays available for approximately 30 days after each event.
argenx (Nasdaq: ARGX), azienda globale nel campo dell'immunologia, ha comunicato che il suo team dirigenziale parteciperà a due conferenze per investitori previste a settembre 2025. L'azienda terrà una presentazione al 2025 Wells Fargo Healthcare Conference il 4 settembre alle 8:00 ET a Boston e al Morgan Stanley 23rd Annual Global Healthcare Conference l'8 settembre alle 7:00 ET a New York.
Gli investitori potranno seguire entrambe le presentazioni in diretta tramite la sezione 'Investors' del sito di argenx; le registrazioni saranno disponibili in replay per circa 30 giorni dopo ciascun evento.
argenx (Nasdaq: ARGX), una compañía global de inmunología, ha anunciado la participación de su equipo directivo en dos conferencias para inversores que se celebrarán en septiembre de 2025. La compañía realizará una presentación en el 2025 Wells Fargo Healthcare Conference el 4 de septiembre a las 8:00 a.m. ET en Boston, y en el Morgan Stanley 23rd Annual Global Healthcare Conference el 8 de septiembre a las 7:00 a.m. ET en Nueva York.
Los inversores podrán acceder a las retransmisiones en directo de ambas presentaciones a través de la sección 'Investors' en la web de argenx; las repeticiones estarán disponibles durante aproximadamente 30 días tras cada evento.
argenx (Nasdaq: ARGX), 글로벌 면역학 기업이 자사의 경영진이 2025년 9월에 열리는 두 건의 투자자 컨퍼런스에 참석한다고 발표했습니다. 회사는 2025 Wells Fargo Healthcare Conference에서 9월 4일 미국 동부시간 오전 8시(보스턴) 발표를 진행하고, Morgan Stanley 23rd Annual Global Healthcare Conference에서는 9월 8일 미국 동부시간 오전 7시(뉴욕)에 발표합니다.
투자자들은 argenx 웹사이트의 'Investors' 섹션을 통해 두 발표의 실시간 웹캐스트를 시청할 수 있으며, 각 행사 후 약 30일간 다시보기(replay)를 제공받을 수 있습니다.
argenx (Nasdaq: ARGX), société internationale en immunologie, a annoncé la participation de son équipe de direction à deux conférences investisseurs en septembre 2025. La société présentera au 2025 Wells Fargo Healthcare Conference le 4 septembre à 8h00 ET à Boston, et au Morgan Stanley 23rd Annual Global Healthcare Conference le 8 septembre à 7h00 ET à New York.
Les investisseurs pourront suivre les deux présentations en direct via la rubrique 'Investors' du site d'argenx ; les rediffusions seront disponibles pendant environ 30 jours après chaque événement.
argenx (Nasdaq: ARGX), ein weltweit tätiges Immunologie-Unternehmen, hat angekündigt, dass sein Managementteam im September 2025 an zwei Investorenkonferenzen teilnehmen wird. Das Unternehmen wird am 2025 Wells Fargo Healthcare Conference am 4. September um 8:00 Uhr ET in Boston präsentieren und am Morgan Stanley 23rd Annual Global Healthcare Conference am 8. September um 7:00 Uhr ET in New York.
Investoren können beide Präsentationen live über den Bereich 'Investors' auf der argenx-Website verfolgen; Wiederholungen sind jeweils etwa 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
August 28, 2025
Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in September:
- 2025 Wells Fargo Healthcare Conference. Fireside chat on Thursday, September 4, 2025 at 8:00 a.m. ET in Boston, MA.
- Morgan Stanley 23rd Annual Global Healthcare Conference. Fireside chat on Monday, September 8, 2025 at 7:00 a.m. ET in New York, NY.
A live webcast of the presentations may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcasts will be available on the argenx website for approximately 30 days following the presentation.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Instagram, Facebook, and YouTube.
Contacts
Media:
Ben Petok
bpetok@argenx.com
Investors:
Alexandra Roy
aroy@argenx.com
FAQ
When is argenx (ARGX) presenting at the Wells Fargo Healthcare Conference 2025?
What time is argenx's presentation at the Morgan Stanley Healthcare Conference 2025?
How can investors access argenx's (ARGX) conference presentations?
What type of company is argenx (ARGX)?
